Biontech

Latest Stories

Editorial Roundup: US

By The Associated Press - Associated Press

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic. (Courtesy of University of Maryland School of Medicine via AP, File)

U.S. sticks to timeline after U.K. vaccine approval

By Tom Howell Jr. - The Washington Times

File -- In this Tuesday, Nov.10, 2020 file photo windows are illuminated at the headquarters of the German biotechnology company BioNTech in Mainz, Germany. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world's first coronavirus shot that's backed by rigorous science -- and a major step toward eventually ending the pandemic.(AP Photo/Michael Probst, file)

Vaccine 1st puts spotlight on German pharma company BioNTech

By DAVID McHUGH and FRANK JORDANS - Associated Press

In this Monday, Nov. 9, 2020 photo, the company sign of BioNtech stands in front of the companies headquarters in Mainz, Germany. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic. (Arne Dedert/dpa via AP)

Who, when and how? A look at the UK’s vaccination rollout

By PAN PYLAS - Associated Press

A woman walks by an electronic stock board of a securities firm in Tokyo, Wednesday, Dec. 2, 2020. Asian markets are mixed after the U.S. benchmark S&amp;P 500 set another record. (AP Photo/Koji Sasahara)

Asian shares inch higher on optimism over vaccines, stimulus

By ELAINE KURTENBACH - Associated Press

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. (Courtesy of University of Maryland School of Medicine via AP, File)

BioNTech, Pfizer ask Europe to OK vaccine for emergency use

By Frank Jordans - Associated Press

FILE- In this Tuesday, Oct. 13, 2020 file photo, South Dakota Governor Kristi Noem speaks in Sioux Falls, S.D. The largest group representing South Dakota doctors has come out in support of a statewide mask mandate as several cities have moved to require masks in public settings. Gov. Noem has opposed government-imposed mask mandates, arguing they have not been proven to halt the spread of infections. She plans to give an update on the state's coronavirus situation later Wednesday, Nov. 18, 2020. (Erin Bormett/The Argus Leader via AP)

South Dakota readies for 7,800 vaccine doses in 2 weeks

By STEPHEN GROVES - Associated Press

CORRECTS: BioNTech and Pfizer ask European regulator for expedited approval of their COVID-19 vaccin

Associated Press

In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection. (AP Photo/Hans Pennink, File)

Moderna asking US, European regulators to OK its virus shots

By Lauran Neergaard - Associated Press

State health official updates lawmakers on vaccine latest

By SARAH RANKIN - Associated Press

A currency trader watches monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, Nov. 27, 2020. Asian stock markets declined Friday as questions about the effectiveness of one possible coronavirus vaccine weighed on investor optimism. (AP Photo/Ahn Young-joon)

Asian stocks gain on stronger Chinese factory data

By JOE McDONALD - Associated Press

Virus news: Businesses see holiday shopping challenges

Associated Press

Britain's Prime Minister Boris Johnson, wearing a mask because of the coronavirus, has a close look at a sample at the Lateral Flow Testing Laboratory during a visit to the Public Health England site at Porton Down science park near Salisbury, southern England, on Friday Nov. 27, 2020. (Adrian Dennis/Pool via AP)

UK appoints vaccines minister to oversee COVID inoculations

By JILL LAWLESS - Associated Press

Doctors and nurses attend to a patient at the intensive care unit for COVID-19 patients in the Andras Josa hospital in Nyiregyhaza, Hungary, Thursday, Nov. 26, 2020 (Attila Balazs/MTI via AP).

The Latest: Illinois surpasses 12,000 deaths from COVID-19

By The Associated Press - Associated Press

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (Courtesy of University of Maryland School of Medicine via AP, File)

Coronavirus vaccine priority: CDC panel to vote Tuesday

Associated Press

FILE - In this Monday, March 16, 2020 file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus at the Kaiser Permanente Washington Health Research Institute in Seattle. A panel of U.S. advisers will meet this week to recommend who should be first in line for a COVID-19 vaccine. Experts have proposed giving the vaccine to health workers first. High priority also may be given to workers in essential industries, people with certain medical conditions and people age 65 and older. (AP Photo/Ted S. Warren, File)

CDC panel meets Tuesday to vote on COVID-19 vaccine priority

Associated Press

File -- In this Tuesday, Nov. 24, 2020 file photo an employee of Binder, the world's largest manufacturer of serial-production environmental simulation chambers for scientific or industrial laboratories, checks an ultra low temperature freezer in Tuttlingen, Germany. Germany prepares for the vaccination of the German population during the upcoming month. (AP Photo/Matthias Schrader, file)

Keep cool: Germany preps vaccine drive as COVID cases hit 1M

By FRANK JORDANS and CHRISTOPH NOELTING - Associated Press

In this undated file photo issued by the University of Oxford on Monday, Nov. 23, 2020, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. With major COVID-19 vaccines showing high levels of protection, British officials are cautiously — and they stress cautiously — optimistic that life may start returning to normal by early April. (University of Oxford/John Cairns via AP, File)

AstraZeneca vaccine to be assessed amid dosing error questions

By Jill Lawless - Associated Press

UK asks regulator to assess AZ-Oxford vaccine amid questions

By JILL LAWLESS - Associated Press

Editorial Roundup: North Carolina

By The Associated Press - Associated Press